跳至主要内容
临床试验/ACTRN12618000497202
ACTRN12618000497202已完成未知

Accuracy of the calcium-creatinine ratio in spot urine sample in prediction of preeclampsia

Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.0 个研究点目标入组 246 人开始时间: 2018年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
246

研究概览

简要总结

Research question: Accuracy of the calcium-creatinine ratio (CCR) in a spot urine sample for the prediction of preeclampsia (PE). Background: Currently, there is no reliable diagnostic test to predict preeclampsia. Participants: Two hundred and forty-six pregnant women, attending the ante-natal clinic after 20 weeks` gestation were included in this study. After exclusion of pre-existing chronic renal disease affecting calcium and/or creatinine excretion, spot urine samples were taken from participants to detect the calcium-creatinine ratio. Results: The calcium-creatinine ratio = 0.04 had 79.3% sensitivity, 96.3% specificity, 91.5% positive predictive value (PPV), 90.3% negative predictive value (NPV), and 90.7% overall accuracy in prediction of preeclampsia. Limitation: Women who refused to participate and/or give consent was the only limitation faced during this study.

研究设计

研究类型
Observational

入排标准

年龄范围
20 Years 至 40 Years(—)
性别
Female

入选标准

  • The study will include women between 20-40 years old, attending the ante-natal clinic of for ante-natal care during the period from May 2018 till May 2020 after informed consent, and approval of the Obstetrics department .
  • Women <20 years, >40 years age, refused to participate in the study and/or refused to give consent will excluded from the study.
  • A complete obstetrical history, clinical examination, the necessary investigations will be done to exclude other conditions affecting urinary calcium/creatinine ratio.
  • As part of the routine follow-up in the ante-natal clinics, the urine sample taken from the pregnant women for urine albumin assessment, will be used for the assessment of the calcium-creatinine ratio after informed consent. Follow–up of the studied women till delivery; women who will develop preeclampsia will constitute the study group, and other normotensive women without preeclampsia will constitute the controls.

排除标准

  • Women <20 years, >40 years age, refused to participate in the study and/or refused to give consent will excluded from the study.

研究者

发起方
Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.

相似试验